Depression is an incapacitating psychiatric ailment and widely recognized as one of the three major diseases of the new century, besides cancer and AIDS . Antidepressants are commonly used to treat depression; however, most of them were withdrawn from treatment due to serious side effects . Therefore, new drugs with high efficiency and low toxicity are urgently required for treating depression. MH, an absorbed bioactive compound from Chaihu-Shugan-San (CSS), displayed potent preclinical anti-depression and gastrointestinal prokinetic functions , , rendering it a prospective candidate to treat depression. However, several questions need to be answered in order for MH to be introduced as a new antidepressant.

